S. Mozaffari

发表

On the Use of Herbal Medicines in Management of Inflammatory Bowel Diseases: A Systematic Review of Animal and Human Studies

M. Abdollahi, R. Rahimi, S. Mozaffari, 2009, Digestive Diseases and Sciences.

A Review on the Role of Oxidative Stress and Inflammation in Necrotizing Enterocolitis and Benefits of the Phosphodiesterase Inhibitor Pentoxifylline

M. Abdollahi, S. Mozaffari, 2013 .

New biologic therapeutics for ulcerative colitis and Crohn's disease

S. Nikfar, M. Abdollahi, S. Mozaffari, 2014, Expert opinion on biological therapy.

Induction of Inflammatory Bowel Disease Through Activation of Immune System Against Enteric Bacteria

M. Abdollahi, M. Baeeri, S. Mozaffari, 2014 .

Beneficial effect of butyrate, Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis.

M. Abdollahi, M. Baeeri, S. Mozaffari, 2014, World journal of gastroenterology.

Synergistic effect of probiotics, butyrate and l-Carnitine in treatment of IBD

M. Abdollahi, S. Mozaffari, S. Ghasemi-Niri, 2013 .

Benefit of Aloe vera and Matricaria recutita mixture in rat irritable bowel syndrome: Combination of antioxidant and spasmolytic effects

M. Abdollahi, M. Baeeri, S. Mozaffari, 2012, Chinese journal of integrative medicine.

Methylnaltrexone bromide for the treatment of opioid-induced constipation

S. Nikfar, M. Abdollahi, S. Mozaffari, 2018, Expert opinion on pharmacotherapy.

Phase II drugs under clinical investigation for the treatment of chronic constipation

S. Nikfar, M. Abdollahi, S. Mozaffari, 2014, Expert opinion on investigational drugs.

Effects of Hypericum perforatum extract on rat irritable bowel syndrome

M. Abdollahi, M. Baeeri, R. Rahimi, 2011, Pharmacognosy magazine.

Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome

S. Nikfar, M. Abdollahi, S. Mozaffari, 2013, Expert opinion on drug metabolism & toxicology.

Tumor Necrosis Factor-alpha Antibodies in Fistulizing Crohn's Disease: An Updated Systematic Review and Meta-analysis

S. Nikfar, M. Abdollahi, S. Mozaffari, 2017, Journal of research in pharmacy practice.

Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs

S. Nikfar, M. Abdollahi, S. Mozaffari, 2015, Human & experimental toxicology.

Inflammatory bowel disease therapies discontinued between 2009 and 2014

S. Nikfar, M. Abdollahi, S. Mozaffari, 2015, Expert opinion on investigational drugs.

The pharmacological management of constipation in patients with Parkinson’s disease: a much-needed relief

S. Nikfar, M. Abdollahi, S. Mozaffari, 2020, Expert opinion on pharmacotherapy.

Differences in Inflammation, Apoptosis and Tissue Hypo-perfusion Indicators Caused by Using Two Different Gauges in Cecal Ligation and Puncture-induced Rat Models of Sepsis

Hamed Haghi-Aminjan, A. Najafi, M. Mojtahedzadeh, 2020 .

A systematic review of the safety of probiotics

S. Nikfar, M. Abdollahi, S. Mozaffari, 2014, Expert opinion on drug safety.

Better Efficacy of Lactobacillus casei in Combination with Bifidobacterium bifidum or Saccharomyces boulardii in Recovery of Inflammatory Markers of Colitis in Rat

M. Abdollahi, M. Baeeri, S. Mozaffari, 2012 .

Investigational opioid antagonists for treating opioid-induced bowel dysfunction

S. Nikfar, M. Abdollahi, S. Mozaffari, 2018, Expert opinion on investigational drugs.

The safety of novel drugs used to treat irritable bowel syndrome

S. Nikfar, M. Abdollahi, S. Mozaffari, 2014, Expert opinion on drug safety.

Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.

S. Nikfar, M. Abdollahi, S. Mozaffari, 2015, World journal of gastroenterology.

Mitochondrial contribution to cell death

M. Abdollahi, S. Mozaffari, 2021, Mitochondrial Metabolism.

Implications of melatonin therapy in irritable bowel syndrome: a systematic review.

M. Abdollahi, R. Rahimi, S. Mozaffari, 2010, Current pharmaceutical design.

Is there an appropriate strategy for treating co-morbid irritable bowel syndrome and bladder pain syndrome?

A. Papatsoris, S. Nikfar, M. Abdollahi, 2019, Expert opinion on pharmacotherapy.

The Mechanisms of Positive Effects of Melatonin in Dyslipidemia: A Systematic Review of Animal and Human Studies

M. Abdollahi, S. Mozaffari, Shirin Hasani-Ran, 2012 .

Melatonin, a promising supplement in inflammatory bowel disease: a comprehensive review of evidences.

M. Abdollahi, S. Mozaffari, 2011, Current pharmaceutical design.

Beneficial effect of butyrate, Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis.

M. Abdollahi, M. Baeeri, S. Mozaffari, 2014, World journal of gastroenterology.